It’s normal to feel wiped out after a hectic week, a poor night’s sleep or a lingering cold. But for some people, exhaustion isn’t something that goes away after rest. It becomes a constant companion ...

In a trial, rituximab demonstrated clinical efficacy in reducing proteinuria in patients with FRNS or SDNS. Intravenous rituximab is safe and effective in patients with frequently relapsing nephrotic ...

The Pixar Era kicked off 30 years ago with the first installment of the popular franchise. It’s given us countless hits, but something has also been lost. By Maya Phillips There are so many ways of ...

Long QT syndrome is a leading cause of sudden death in young persons, with a prevalence exceeding 1 in 2000. It is characterized by prolongation of the QT interval, aberrant T-wave morphologic ...

Is “Trump derangement syndrome” real? No serious mental-health professional would render such a partisan and derogatory diagnosis. Yet I’ve seen it in my own psychotherapy practice. Patients across ...

Findings showed a greater proportion of patients achieved sustained complete remission with obinutuzumab vs mycophenolate mofetil at week 52. Topline data were announced from a phase 3 study ...

Primary nephrotic syndrome in adults is characterized by severe proteinuria and hypoalbuminemia. This was the first clinical trial to test rituximab in adult-onset frequently relapsing nephrotic ...

One monoclonal antibody, rituximab, can work wonders for the treatment of children with frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome. However, what about patients ...

Osaka, Japan – One monoclonal antibody, rituximab, can work wonders for the treatment of children with frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome. However, what ...

– If approved, Gazyva could help children and young adults sustain remission, potentially with a reduced need for steroids to manage their disease – – INShore is the first global Phase III study of a ...